Monday, September 14, 2026

Coupang Says Will Provide Responsible Compensation, Not In Violation Of US Laws

Coupang's interim CEO, Harold Rogers, addresses a data breach at a National Assembly hearing, committing to customer compensation and security improvements.

China’s Atlantic Amsterdam Platform Moves: What This Means for Sino-Korean Relations?

China is relocating its maritime platform Atlantic Amsterdam from the Korea-China Provisional Measures Zone, easing tensions with South Korea.

Beijing Meeting Could Signal New Diplomatic Gamble for North Korea

Kim Jong Un's upcoming visit to China marks a potential shift in North Korea's diplomatic strategy, responding to U.S.-South Korea ties.

Tag: acquisition

SK Biopharmaceuticals Acquires Opacalim: What This 795 Million USD Epilepsy Drug Deal Means for Patients

SK Biopharmaceuticals has acquired a new epilepsy drug candidate from Biohaven Bioscience, enhancing its portfolio in neurology.

Samsung Biologics Launches 3 Billion USD Stock Offering to Acquire Polypeptide Group: What This Means for the Global CDMO Market

Samsung Biologics plans a 2.3 billion USD capital increase to become a top-tier CDMO, primarily for acquiring Polypeptide Group.

SK Biopharmaceuticals Secures 795 Million USD License for Groundbreaking Epilepsy Drug Opacalim – What You Need to Know

SK Biopharmaceuticals acquires epilepsy drug candidate from Biohaven for 795 million USD, enhancing its global biotech portfolio.

Celltrion Completes Integration of France’s Gifrer, Targets European Pharmacy Network

Celltrion has completed the post-acquisition integration of French health care company Gifrer and plans to use its pharmacy network as a hub for expanding direct sales across Europe.

Samsung Biologics Accelerates “Three-Pillar Expansion Strategy” With Peptide CDMO Acquisition to Drive Global Growth

Samsung Biologics acquires Polypeptide Group for $1.8 billion, expanding into the peptide CDMO market to enhance growth and capabilities.

Hanmi Pharmaceutical completes acquisition of Aptose Biosciences

Hanmi Pharmaceutical has acquired Aptose Biosciences for $46.7 million, regaining rights to the cancer drug tuspetinib.

Pharmaresearch Acquires CG USA to Strengthen Localization Strategy for Rejuran Cosmetics in the U.S.

Pharmaresearch acquires CG USA to enhance supply chain and meet growing demand for Rejuran Cosmetics in North America.

Shaperon to Expand Biobeauty Business With NeedsTech, Targeting Hong Kong, Taiwan and U.S. Markets

Shaperon is acquiring NeedsTech to enhance its biobeauty business and expand globally, targeting markets in Hong Kong, Taiwan, and the U.S.

Shaperon’s Acquisition of Niztech Signals Convergence of Biotechnology and Medical Devices

Shaperon's acquisition of Niztech signals a strategic shift towards expanding into medical devices and consumer markets in healthcare.

AI Search Revolution: How AXZ’s AI Overview and AI Mode Will Transform Your Online Experience in 2026

Major portals are leveraging AI to enhance search capabilities, focusing on personalized and vertical search experiences for users.

Shaperon Acquires Beauty Device Maker NeedsTech, Targets Revenue Growth in Second Half

Shaperon acquires NeedsTech to diversify into beauty devices, aiming for stable revenue while advancing its biotech pipeline.

LG Electronics Launches Korea’s First Robot Data Factory: What This Means for Humanoid Robots in 2026

LG Electronics is launching South Korea's first Robot Data Factory to enhance humanoid robots, marking a significant step in AI robotics.

CG MedTech Acquires Human Tissue Processing Bank: What This Means for the Bio Sector in 2026

CG MedTech acquires a human tissue processing bank, expanding into bio business with ECM-based therapeutics and dental materials.

How OpenAI’s Parameter Golf Challenge is Redefining Talent Acquisition in the AI Era

OpenAI is revolutionizing hiring by evaluating real-world skills through a new AI model challenge, aiming to attract top talent in the industry.

Top News

- Our Sponsors Ad -

Follow us